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Available online 21 February 2016Background: Frontotemporal dementia (FTD) is a heterogeneous neurodegenerative disorder with a strong
genetic component. The cerebellum has not traditionally been felt to be involved in FTD but recent research
has suggested a potential role.
Methods:We investigated the volumetry of the cerebellum and its subregions in a cohort of 44 patients with ge-
netic FTD (20MAPT, 7 GRN, and 17 C9orf72mutation carriers) comparedwith 18 cognitively normal controls. All
groupswerematched for age and gender. On volumetric T1-weightedmagnetic resonance brain imageswe used
an atlas propagation and label fusion strategy of the Diedrichsen cerebellar atlas to automatically extract subre-
gions including the cerebellar lobules, the vermis and the deep nuclei.
Results: The global cerebellar volume was signiﬁcantly smaller in C9orf72 carriers (mean (SD): 99989 (8939)
mm3) compared with controls (108136 (7407) mm3). However, no signiﬁcant differences were seen in the
MAPT and GRN carriers comparedwith controls (104191 (6491)mm3 and 107883 (6205)mm3 respectively). In-
vestigating the individual subregions, C9orf72 carriers had a signiﬁcantly lower volume than controls in lobule
VIIa-Crus I (15% smaller, p b 0.0005), whilst MAPT mutation carriers had a signiﬁcantly lower vermal volume
(10% smaller, p = 0.001) than controls. All cerebellar subregion volumes were preserved in GRN carriers com-
pared with controls.
Conclusion: There appears to be a differential pattern of cerebellar atrophy in the major genetic forms of FTD,
being relatively spared in GRN, localized to the lobule VIIa-Crus I in the superior-posterior region of the cerebel-
lum in C9orf72, the area connected via the thalamus to the prefrontal cortex and involved in cognitive function,
and localized to the vermis inMAPT, the ‘limbic cerebellum’ involved in emotional processing.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Keywords:
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C9orf721. Introduction
Frontotemporal dementia (FTD) is a clinically, pathologically and
genetically heterogeneous neurodegenerative disorder, commonly pre-
senting with progressive impairment in behaviour (behavioural variant
FTD, bvFTD) or language (primary progressive aphasia, PPA). Around a
third of patients with FTD have an autosomal dominant mutation in
one of three genes: microtubule-associated protein tau (MAPT),
progranulin (GRN) and chromosome 9 open reading frame 72 (C9orf72)
(Rohrer and Warren, 2011). Neuroimaging and pathological studies of
FTD have emphasized the key roles of the frontal, temporal, insular and
cingulate cortices as well as subcortical structures such as the striatumpartment of Neurodegenerative
ndon, WC1N 3BG, UK.
. This is an open access article underand thalamus, but minimal attention has been paid to the potential role
of the cerebellum.
Although its function has traditionally been felt to be related solely
to the co-ordination of movement, research over the past twenty
years has highlighted a role for the cerebellum in cognitive and emo-
tional processing (Schmahmann, 1991; D'Angelo and Casali, 2013;
Middleton and Strick, 2000; Strick et al., 2009; Makris et al., 2003). It
is extensively connected with different brain regions, including key
areas involved in FTD, e.g. via the thalamus to the prefrontal cortex
(Behrens et al., 2003; Palesi et al., 2015), and to the limbic system via
a direct cerebello-limbic pathway (Arrigo et al., 2014).
Interest in the cerebellum in FTD has arisen from the association of
C9orf72mutationswith cerebellar pathology at post-mortem and a num-
ber of voxel-based morphometry MRI studies have now found involve-
ment of the cerebellum in this group (Whitwell et al., 2012; Irwin et al.,
2013; Mahoney et al., 2012; Rohrer et al., 2015). However detailed re-
gion of interest studies have not been performed, nor direct comparisonthe CC BY license (http://creativecommons.org/licenses/by/4.0/).
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288 M. Bocchetta et al. / NeuroImage: Clinical 11 (2016) 287–290across the different major genetic forms of FTD. Therefore, the aim of
this study was to investigate the volume of the cerebellum and its sub-
regions in a cohort of genetic FTD patients, and to determine whether
speciﬁc cerebellar regions are associated with genetic mutations in
MAPT, GRN and C9orf72 genes.
2. Methods
We reviewed the UCL Dementia Research Centre FTD database to
identify all patients who were symptomatic carriers of a mutation in
the MAPT, GRN or C9orf72 genes and who had also undergone a volu-
metric T1-weighted MRI. 44 patients were identiﬁed: 20 MAPT (19
with bvFTD and one with a corticobasal syndrome), 7 GRN (3 bvFTD
and 4 PPA) and 17 C9orf72 (13 bvFTD, 2 FTD with motor neurone dis-
ease and 2 PPA). No signiﬁcant differences were seen in age at scan
(p = 0.071, Kruskal–Wallis test) or gender (p = 0.301 Chisquare test)
between the groups: 57.6 (7.1) years for MAPT (75% male), 63.0 (7.0)
years for GRN (43% male) and 61.4 (6.7) years for C9orf72 (65% male).
Disease duration at time of scan was signiﬁcantly different between
the groups (p = 0.026, Kruskal–Wallis test): 7.0 (4.3) years forMAPT,
2.7 (1.9) for GRN and 6.0 (4.1) years for C9orf72. However, each genetic
FTD cause is known to vary in its disease progression and so we exam-
ined whole brain volume (corrected for total intracranial volume, TIV)
as a proxy of overall disease stage. No signiﬁcant differences were
seen between the groups (p = 0.610, Kruskal–Wallis test): 1108.8
(388.7) cm3 for MAPT, 1118.9 (411.7) cm3 for GRN and 1098.1 (661)
cm3 for C9orf72, suggesting that the groups were approximately
matched for disease severity. Eighteen cognitively normal subjects,
with a similar age and gender to the carriers,were identiﬁed as controls:
56.4 (14.3) years (50% male). The study was approved by the local
ethics committee and written informed consent was obtained from all
participants.
Raw MR images were pre-processed to correct for magnetic ﬁeld
bias (inhomogeneity) using a non-parametric non-uniform intensity
normalization (N3) algorithm (Sled et al., 1998; Boyes et al., 2008).
We then used an atlas propagation and label fusion strategy of the
Diedrichsen cerebellar atlas to automatically extract subregions of the
cerebellum: the cerebellar lobules (I-IV, V, VI, VIIa-Crus I, VIIa-Crus II,
VIIb, VIIIa, VIIIb, IX and X), the vermis and the deep nuclei (dentate, in-
terposed and fastigial) (Cardoso et al., 2015; Diedrichsen et al., 2009,
2011). No signiﬁcant asymmetry was noted in the volumes and so
right and left-sided results were combined for each subregion. All vol-
umes were corrected for TIV, which was calculated using the Statistical
Parametric Mapping (SPM) 12 software, version 6470 (www.ﬁl.ion.ucl.
ac.uk/spm), running under Matlab R2014b (Math Works, Natick, MA,
USA) (Malone et al., 2015). Statistical analyses were performed in
SPSS software (SPSS Inc., Chicago, IL, USA) version 22.0,with differences
in volumes of the cerebellar lobules, vermis and deep nuclei between all
groups tested using the Mann–Whitney U test.
3. Results
C9orf72mutation carriers showed the lowest global cerebellar vol-
ume (mean (SD): 99989 (8939) mm3), signiﬁcantly smaller than con-
trols (108136 (7407) mm3, p = 0.006 on Mann–Whitney U test), and
the GRN group (107883 (6205) mm3, p = 0.028), but not from the
MAPT group (104191 (6491) mm3; p = 0.080). No signiﬁcant differ-
ences were seen in the GRN or MAPT groups in comparison with each
other or the control group (p = 0.196, MAPT versus controls; p =
0.836, GRN versus controls; p = 0.370, GRN versusMAPT).
For the 14 individual subregions of the cerebellum, a Bonferroni cor-
rection for multiple comparisons was made so that only a threshold of
p b 0.003 was considered signiﬁcant. The C9orf72 group showed a sig-
niﬁcantly lower volume compared with controls of the lobule VIIa-
Crus I only (p b 0.0005, 15.2% smaller than controls), whilst theMAPT
group showed a signiﬁcantly lower volume of the vermis only (p =
289M. Bocchetta et al. / NeuroImage: Clinical 11 (2016) 287–2900.001, 9.5% smaller than controls) (Table 1 and Fig. 1). No other subre-
gion reached statistical signiﬁcance but there was a trend for lower vol-
umes of the interposed nuclei in both the C9orf72 and MAPT groups
compared with controls (p = 0.004 and p = 0.007, respectively). GRN
carriers showed preserved cerebellar volumetry with no signiﬁcant dif-
ferences from controls.
4. Discussion
We found a differential pattern of regional cerebellar involvement in
the different genetic forms of FTD: lobule VIIA-Crus I in C9orf72, the ver-
mis inMAPT, and sparing in the GRN group. Lobule VIIa-Crus I has been
associatedwith cognitive processing including the direction of complex
goal-directed behaviours, through its connections via the ventrolateral
and ventroanterior thalamus to the prefrontal cortex (Makris et al.,
2003; Palesi et al., 2015; D'Angelo and Casali, 2013). Although the
vermis is involved in the integration of sensory input with motor com-
mands (Bogovic et al., 2013; Schmahmann, 2000;Makris et al., 2003), it
is also considered the ‘limbic cerebellum’, involved in themodulation of
emotions and social behaviours, based on its connections with the lim-
bic brain structures (Schmahmann, 2000; Stoodley and Schmahmman,
2009; Arrigo et al., 2014; Makris et al., 2003).
The involvement of the cerebellum, and particularly the superior-
posterior area, in C9orf72mutation carriers is consistent with previousFig. 1. Segmentation of the cerebellar lobules anddeepnuclei (left side)mapped on a T1-weight
FTD are mapped on the same MR image.studies (Whitwell et al., 2012; Irwin et al., 2013; Mahoney et al.,
2012), but here is localized to a speciﬁc lobule (VIIa–Crus I) which is
known to be linked to the thalamus, a key area of atrophy in C9orf72 car-
riers, and then on to the prefrontal cortex (Behrens et al., 2003; Palesi
et al., 2015). Degeneration of a cerebello-thalamic-cortical network has
been proposed to underpin disturbances of body schema and related
neuropsychiatric symptoms in this group (Downey et al., 2014), and is
an early (presymptomatic) feature of the disease (Rohrer et al., 2015).
Identiﬁcation of vermal involvement inMAPT carriers in this region
of interest study is unsurprising given what is known about the pattern
of atrophy in this group, where limbic structures are predominantly in-
volved, particularly the amygdala, hippocampus and hypothalamus,
which are linked to the cerebellum via the cerebello-limbic pathway
(Rohrer et al., 2010; Bocchetta et al., 2015). Patients withMAPTmuta-
tions commonly present with impaired social conduct and behaviour,
and it is likely that degeneration across the limbic network leads direct-
ly to these symptoms.
There is a clear trend to involvement of the interposed nuclei in both
C9orf72 andMAPT groups. As part of the deep cerebellar nuclei, they re-
ceive intrinsic inputs from the cerebellar cortex to be sent to the other
cortical regions via the ventroanterior and ventrolateral thalamic nuclei
(Granziera et al., 2009; Makris et al., 2003), and are likely to be part of
the cerebello-thalamic-cortical network in C9orf72 carriers and the
cerebello-limbic network inMAPT carriers.ed3TMR image of a control subject. On the right panel signiﬁcant volumetric differences in
290 M. Bocchetta et al. / NeuroImage: Clinical 11 (2016) 287–290In summary, we found that mutations inMAPT and C9orf72 have a
differential impact on the cerebellum with GRN carriers having no sig-
niﬁcant impact. The regions involved are part of different brain net-
works that are intrinsically linked to the development of the
symptoms seen in each of these genetic disorders. It will be impor-
tant to investigate how early these regions may become affected
using data from presymptomatic FTD cohorts such as GENFI (Rohrer
et al., 2015). Furthermore, future studies on functional and structural
connections of the cerebellum will be helpful in clarifying the role of
these networks in genetic FTD.
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